InvestorsHub Logo
Followers 2
Posts 483
Boards Moderated 0
Alias Born 04/03/2017

Re: cjarmstrong post# 2971

Wednesday, 11/15/2017 10:07:01 PM

Wednesday, November 15, 2017 10:07:01 PM

Post# of 6315
It was Insys and No one hear new that

Not old news. Insys was willing to sell a Painkiller 100x more powerful than standard opiod to people with back pain. The fact they didn't think it was marketable says something. Insys has No morals at all

Instead of Negotiating with ElSohly and taking what turned out to be NB1222 to clinical trials immediately, they chose to spend More money and More Time developing Syndros. This from the Company who's only concern the last 5 years was How much fentanyl they could sell and how fast they could do it.

Short-term Profit-blinded bottom of the barrel people. But they still said it was a no go

It only gets worse from Here